chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I experienced issues with my blood pressure and blood sugars. At first I didn't check it, I noticed some time during the day I would get really tired and sometimes fall asleep. I was very active prior to the vaccination.  I was taking care of my husband at the time so I did not immediately see a doctor. I would lye down and rest and just take Tylenol. I also experienced right shoulder pain as well. The doctor ordered me Meloxicam on 11-24-2021. She did a chest x-ray and a CT Scan. The doctor thought that the arm pain was triggered from my back. The chest x-ray said I had compression fractures but the CT scan said I had no compressions. After taking the medication for a month, it did not do anything. This continued until I had my booster vaccine January 05 of 2022 (Pfizer Booster-fj1614). After receiving the booster dose, my symptoms became worse. That night after my booster, my left arm had sever pain and I was unable to use it. I had the pain for 2 days where I was unable to use my arm period. I had a arm brace that I wore which kinda helped and then after 2 days the pain went away. I was ashamed to tell the doctor because it did sound crazy. Within days, it started in my right upper arm but was not in the joint. I was in the area where you get a shot and ran down to my elbow. It would get a little bit better and then it moved to my hips in the groin area. Then it started in my left ankle. I thought that I would need to use a cane. I then got it in my left upper arm so I went to see an orthopedic doctor on 2-22-2022. They completed a chest x-ray.  The provider indicated that he did believe it was related to the booster. He indicated that he could give a cortisone shot or a steroid pack. He would not provide NSAIDS. I just started the steroid pack yesterday. I have 5 days of treatment remaining. I am returning to the provider in 4 weeks for follow up. Today seems to be pretty good, I am not having the pain like normal. I am experiencing pain in my right upper arm.
Moderna COVID- 19 Vaccine EUA: Patient presented to emergency department two days after receiving vaccination and three days after symptoms of feeling ill and body aches started. Patient also reports fatigue and back pain. On exam patient had myalgias, dyspnea, cough, chills, fatigue, tachypnea (23 breaths per minute), and fever (39 degrees Celsius). Other vital signs within normal ranges. Administered intravenous fluids and antibiotics and admitted to another facility for further treatment. Patient discharged to home two days later with symptoms either resolved or returned to baseline.
This spontaneous report as received from a other health professional refers to a 6 month old patient who on 20-FEB-2014, was vaccinated with a 2.0 ml dose of ROTATEQ oral (lot number H012252) that was expired. The vaccine expired on 29-JAN-2014. No adverse effects were reported. This is one of several reports from the same source. Additional information has been requested.
Within 6 hours of receiving first covid shot, I started getting a headache a little after midnight. The next day was a full blown migraine like an ice puck being jammed in my brain. Also had nauseousness for most of the day. Body aches. Also a heavy, depression feeling.
L deltoid edematous, circumference increased significantly, hot to touch; treated with antibiotic; much improved after a week.
Swollen tongue; sore throat; headache; increased body/joint aches; fatigue; nausea; vomiting (1 episode)
Patient has had diffuse myalgias. Treatment (Tylenol).  Was evaluated today (11/2/2011) and still has myalgias.
Patient vaccinated at 10:18am by mobile vaccinator. At 10:48am patient reported symptoms of headache rated 4/10, chest heaviness that lasted a ?few? moments, and lightheadedness. Patient?s 30 minute wait increased to 45 minutes by mobile team. Patient given Gatorade and instructed to recline seat, patient declined any breathing issues. Patient?s new wait time now 11:03am from 10:48am. When checking on patient at 11:05am, patient informed her headache has increased and moved to sinuses and reported chest heaviness had returned. Patient?s spouse reported that patient used her inhaler before the RN came to car. MBC paged at 11:08am to come for further evaluation. Patient?s vital signs taken at 11:15am were a pulse of 84, blood pressure of 138/82, and pulse oximetry of 97%. Patient was alert and oriented to person, place, time, and event. And able to hold a conversation. MBC called EMS at 11:17am, and continued to monitor patient for any status changes. No hives, itchiness, tongue swelling, or respiratory obstruction were noted. EMS arrived at 11:29am and performed an evaluation. Vital signs were a pulse of 89, blood pressure of 145/89, and pulse oximetry of 96% at room air. At 11:35am, patient reported muscle pain in her chest that radiated up to her shoulders, and no acute distress or respiratory issues. Patient declined EMS transport and left the site at 11:44am. Provided education to patient and told to follow up with primary care doctor, and if symptoms worsen to head to the nearest ER or Call EMS. Patient and spouse verbalized understanding of the education. Patient left in the passenger side of the car, spouse was driving the vehicle.
4 days following injection, onset of severe headache..days 5-6, headache untouched by Sumatriptin...day 6 made appointment with Neurologist...days 6-7, headache again untouched by Sumatriptin...day 7 awoke with rash on right side of forehead, right eye swollen, right ear painful...day 8 saw neurologist and internist and started on antiviral and prednisone...day 9,  slight improvement, enough to be encouraged
aches, chills, joint pain, muscle fatigue, generalized fatigue, loss of mobility
Information has been received from a RN concerning a 5 year old white female with no known medical history who on 06/14/00 was vaccination with in the LUA with a first 0.5cc dose of varicella virus vaccine live. There was no concomitant medication. On 06/16/2004 the pt was exposed to chickenpox. On 06/21/04 the pt's mom noticed a couple of raised spots with a red base on her arms and one behind her neck. By 07/22/2004 a few more had appeared sporadically over her body. The pt complained of itching but feeling ok overall. On 07/22/2004 the pr was seen by the physician and varicella was confirmed. Symptomatic care was discussed. The pt recovered on 08/04/2004. No further information is available.
Vaccination site rash; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Vaccination site rash) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Psoriatic arthritis and Rheumatoid arthritis.    No Medical History information was reported.   On 11-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On an unknown date, ADALIMUMAB (HUMIRA) (Subcutaneous) dosage was changed to UNK, citrate free. In October 2021, the patient experienced VACCINATION SITE RASH (Vaccination site rash). In October 2021, VACCINATION SITE RASH (Vaccination site rash) had resolved.       The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No concomitant medication details were provided. No treatment medication details were provided.   The reporter's causality for the event of vaccination site rash with HUMIRA was not provided.  It was unknown if patient was enrolled in a COVID-19 Vaccine Trial.  Primary reporter did not have the lot number information, because the information was not available in the patient's file.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
Fever, body aches, cough, starting a few hours after flu vaccine. Headache.
A 4x4 inch area on the right thigh of mild swelling and erythema that is resolving.
Tiredness; hyper sensitive reaction; achiness,ankle pain and top of the foot is painful / sore arm; itchy rash(red) all over trunk(front/back)and underarms; bleeding rash; rash moved to her chest ( including breast and nipples) as well as to the back of her head; Shoulder joint pain; red; raised bumps not welty; feel itchy in her back and underarm; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (feel itchy in her back and underarm), PURPURA (bleeding rash), ERYTHEMA (red), RASH PAPULAR (raised bumps not welty) and RASH (rash moved to her chest ( including breast and nipples) as well as to the back of her head) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by reporter.  Concurrent medical conditions included Asthma, Allergy to antibiotic and Allergy to animals. Concomitant products included OMEPRAZOLE for GERD, MULTIVITAMIN [VITAMINS NOS] for an unknown indication.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced PRURITUS (feel itchy in her back and underarm), ERYTHEMA (red) and RASH PAPULAR (raised bumps not welty). On 09-Apr-2021, the patient experienced PURPURA (bleeding rash), RASH (rash moved to her chest ( including breast and nipples) as well as to the back of her head), ARTHRALGIA (Shoulder joint pain) and RASH PRURITIC (itchy rash(red) all over trunk(front/back)and underarms). On 10-Apr-2021, the patient experienced MYALGIA (achiness,ankle pain and top of the foot is painful / sore arm). On an unknown date, the patient experienced FATIGUE (Tiredness) and HYPERSENSITIVITY (hyper sensitive reaction). The patient was treated with IBUPROFEN at a dose of 1 dosage form; DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 1 dosage form and CORTISONE at a dose of 1 dosage form. At the time of the report, PRURITUS (feel itchy in her back and underarm), PURPURA (bleeding rash), ERYTHEMA (red), RASH PAPULAR (raised bumps not welty), RASH (rash moved to her chest ( including breast and nipples) as well as to the back of her head), ARTHRALGIA (Shoulder joint pain), MYALGIA (achiness,ankle pain and top of the foot is painful / sore arm) and HYPERSENSITIVITY (hyper sensitive reaction) had not resolved and FATIGUE (Tiredness) and RASH PRURITIC (itchy rash(red) all over trunk(front/back)and underarms) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-267089 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 26-Jul-2021: Significant Followup Patient historical condition and demographic details was updated.
Crohn's Flare Up; Brain Fog; fever; cramps and major abdominal pain; cramps and major abdominal pain; heart rate increased; neck area twitching and in face; This is a spontaneous report from a contactable consumer (patient). A 48-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in left arm on 05Jun2021 15:00 (Batch/Lot number was not reported) at the age of 48 years old as dose number unknown, single for COVID-19 immunization. Medical history included ongoing Crohn's.  The patient's concomitant medications were not reported. The patient previously took fexofenadine (ALLEGRA) and fluoxetine (PROZAC), with known allergies to both. No other vaccine was received in four weeks. No other medications in two weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 05Jun2021 19:00, the patient experienced Crohn's flare up, brain fog, fever, cramps and major abdominal pain, heart rate increased, and neck area twitching and in face. Adverse events (AE) resulted in doctor or other healthcare professional office/clinic visit. No treatment received for AE. Outcome of events was recovering.  Information about batch/lot number has been requested.
Exactly 5 days after the second dose of the Pfizer covid-19 vaccine, I suffered an ischemic stroke.  There was a blood clot in my brain that was broken up after tPA was administered about 2 hours after the symptoms of the stroke set in. To date (May 30) I have had many tests, including 2 MRIs, CT scans, TEE, heart monitoring etc.    So far, it has been called a "cryptogenic stroke" because there is no cause.  The only thing different was the vaccine I received 5 days before the stroke.
COVID booster was to be given at the end of pt visit.  Patient did not have his COVID card.  The system was checked to verify other vaccines given.  Patient stated he just needed a booster shot.  The vials were labeled as  Bivalent Moderna, and a Bivalent Moderna dose of 0.5 mL was drawn up and injected into pt.  As the nurse was charting the dose given, then realized the vials were marked incorrectly and were actually Bivalent Pfizer vaccine and the incorrect dose had been given, when the dose should have been 0.3 mL.   The patient did not have an adverse reaction to the vaccine, just incorrect dose given.
Fever of 101; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever of 101) in an 86-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20a) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced PYREXIA (Fever of 101). At the time of the report, PYREXIA (Fever of 101) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Jan-2021, Body temperature: 101 degree (plane angle).     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Case previously recorded as MA2009-4400.  Initial case report received from a nurse via agency on 16 NOV 2009.  A patient 3-year-old male was vaccinated with 0.5mL FLUVIRIN 2009/2010 (batch no. 102045P1) i.m. on 14 NOV 2009.  Wrong age is unexpected after vaccination with S-OIV FLUVIRIN 2009/2010.  No change in benefit-risk-ratio.  No measures necessary.  Agency reference no.: NA09-008317.
Palpitations Narrative: Employee elected to remain in observation for an additional 15 minutes and reported an absence of palpitation following a total o 30 min observation.
Immediately after the injection patient felt a pressure like and felt a ball on the back of his head left side that resolved within a day.  Within a week from vaccine patient started having a headache on and off with feeling of like his brain is swelling on the left side. Within another week patient experienced abdominal pain and chest pressure. went to a hospital CT abdomen was negative. On 4/28 patient had a severe headache followed by numbness to left face and left facial droop. 911 was called patient was code stroke in ED.
Tested positive for COVID; Tested positive for COVID; Booster; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 20Dec2021 (Batch/Lot number: unknown) as dose 3 (booster), single, administration date 24May2021 (Batch/Lot number: unknown) as dose 2, single and administration date 03May2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: IMMUNISATION (medically significant) with onset 20Dec2021, outcome "unknown", described as "Booster"; VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 09Jan2022, outcome "unknown" and all described as "Tested positive for COVID". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (09Jan2022) positive. The patient had a slight head cold after the dose 1 and NyQuil got rid of it in few days. Following week after booster dose, patient got a real bad head cold that took a week to go away.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Late menstrual period by 2 weeks and extreme heavy period (thin, clotty) with lots of cramps; Late menstrual period by 2 weeks and extreme heavy period (thin, clotty) with lots of cramps; Late menstrual period by 2 weeks and extreme heavy period (thin, clotty) with lots of cramps; Fever; chills; nausea; headache; muscle heaviness; metal taste in mouth; sinus swelling; sneezing; extreme fatigue; This is a spontaneous report received from contactable consumers (one of them is the patient). A 45-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: ER8737) via an unspecified route of administration, administered in right arm on 22Apr2021 13:00 (at the age of 45-year-old) as 1st dose, single for COVID-19 immunisation. Medical history included high blood pressure and allergy to sulfa drug. Patient was not pregnant. The patient's concomitant medications were not reported. On 23Apr2021 11:45, patient experienced fever, chills, nausea, headache, muscle heaviness, metal taste in mouth, sinus swelling, sneezing and extreme fatigue. On 03May2021 03:00, patient had late menstrual period by 2 weeks and extreme heavy period (thin, clotty) with lots of cramps on an unspecified date when it did came. The patient did not receive treatment for the events reported. Outcome of events was recovering.  No follow-up attempts are needed. No further information is expected.
Pt got vaccine 12/23/2020- then herpes zoster 1/7/2021 so started Valtrex. Started bleeding 1/10/21 and was admitted with platelet count of zero 1/11/2021. Diagnosed with ITP and is responding to prednisone. Also got IVIG. Of note- her dad has a h/o ITP as well and was on Rituxan and also developed low platelet count with each of his COVID vaccines.
Tiredness, sore arm, rash about 3in below injection sight. 3.5 x2.5 in. Itchy.  Occupied 2 days after injection. Put benadryl cream on it. As per Dr.
Patient received an expired dose of the Moderna COVID-19 vaccine from a previously unpunctured vial that had been in their refrigerator sincr 04 Jun 2021; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received an expired dose of the Moderna COVID-19 vaccine from a previously unpunctured vial that had been in their refrigerator sincr 04 Jun 2021) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jul-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received an expired dose of the Moderna COVID-19 vaccine from a previously unpunctured vial that had been in their refrigerator sincr 04 Jun 2021). On 06-Jul-2021, EXPIRED PRODUCT ADMINISTERED (Patient received an expired dose of the Moderna COVID-19 vaccine from a previously unpunctured vial that had been in their refrigerator sincr 04 Jun 2021) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  No treatment information was reported.
Patient's left arm. 61 year old female with chief complaint of severe rxn to vaccine administered in clinic yesterday. Pt presents with complaint of fever, chills, nausea, dizziness, L arm swelling massively over 24 hours, red, tender, hot. No shortness of breath. Fasciitis/Cellulitis vs. allergic reaction. Temp 99 oral now, BP 108/62 normally 128/81.
The day after I received the vaccine, two joints in my fingers have become very stiff.  The pain is most significant in the morning.  This has not happened before and it has not yet gone away (nearly three weeks have passed).
This case was reported by a pharmacist and described the occurrence of lightheadedness in a 56-year-old male subject who was vaccinated with ENGERIX B (GlaxoSmithKline). Concurrent medications included LIPITOR and BENICAR. On 19 July 2011 the subject received 3rd dose of ENGERIX B (20 mcg, unknown route). On 21 July 2011, 2 days after vaccination with ENGERIX B, the subject experienced lightheadedness. On 22 July 2011 the subject experienced double vision. The pharmacist considered the events were disabling and clinically significant (or requiring intervention). At the time of reporting the events were unresolved. The pharmacist considered the events were possibly related to vaccination with ENGERIX B. No further information was provided and the reporter refused permission for follow-up.
Information has been received from a licensed practical nurse (LPN) concerning a female who on unspecified dates was vaccinated with a first, second and third dose of Gardasil. After vaccination with the second dose, the patient developed a "reaction." No symptoms were described for the patient's reaction. Subsequently, the patient recovered. Due to this information, the patient was monitored for any reaction after the third vaccination. Subsequently, after the third vaccination, the patient developed a seizure while in the physician's office. The patient's symptoms were reported as follows:"arms went stiff and out"; "pupils were fixed and dilated." Unspecified medical attention was provided. The patient's symptoms resolved during the appointment. Upon internal review, seizure was considered to be an other important medical event. Additional information has been requested.
This spontaneous report was received from a physician, via company representative, and refers to a patient of unknown age and gender. Pertinent medical history, concurrent conditions, drug reactions or allergies and concomitant therapies were not reported. On 08-DEC-2015, the patient was vaccinated with a dose of PNEUMOVAX 23 10 PK-0.5 ml SD-PFS LLokwTip, lot # L002310, expiration date 08-JUL-2016, (route and anatomical location of administration were unspecified) which was improperly stored in refrigerator to a temperature excursion of 1.1 Celsius degrees for 208 hours with lowest temperature recorded of 34 Fahrenheit degrees. No adverse effects were reported and no product quality complaint (PQC) was involved. This is one of several reports received from the same reporter. Additional information has been requested.